The response to the COVID-19 pandemic has put the UK Government and NHS on an emergency footing. With this substantial change to NHS services, there has been a rapid growth in published guidelines and policy to help Healthcare Professionals (HCPs) ensure patients get the right treatment and care. Here we have detailed some key sources of information and the more important guidelines that will affect the myeloma community.

Myeloma Specific Guidelines and Information

Information specifically related to myeloma and COVID-19.

UK Myeloma Society COVID-19 guidance

UK Myeloma Society Interim treatment change options for the COVID-19 endorsed by NHS England

Myeloma UK COVID-19 information hub

Cancer Treatment and Care Guidelines

Information relating to the management of cancer treatment and care during the COVID-19 pandemic.


England, Wales and Northern Ireland

NHS England advice for clinicians: Cancer

National Institute of Health and Care Excellence (NICE) Coronavirus (COVID-19) hub

NICE COVID-19 rapid guideline: delivery of systemic anticancer treatments

Interim treatment change options during the COVID-19 pandemic, endorsed by NHS England

COVID-19 rapid guideline: haematopoietic stem cell transplantation

COVID-19 rapid guideline: delivery of radiotherapy



Guidelines for cancer treatment during COVID-19 pandemic

Resources for NHS Scotland in the COVID-19 pandemic

COVID-19 (Coronavirus) and Cancer: Information if you are a patient or carer


General COVID 19 Guidelines

UK Government Coronavirus Guidance including links to ScotlandWales and Northern Ireland information hubs.

Myeloma patients, including those in remission, were specifically referenced as being extremely vulnerable to COVID-19 and were advised to shield.

Advice for England, Wales and Northern Ireland

Advice for Scotland

Guidance and Information from professional organisations

Including advice on vaccinations.

British Society of Haematology (BSH) COVID-19 Updates

Royal College of GP’s Latest COVID-19 guidance

Royal College of Nursing COVID-19 (coronavirus)

European Society of Medical Oncology (ESMO) COVID-19: supporting oncology professionals

European Myeloma Network: Consensus paper on management of patients with multiple myeloma and COVID-19 in the post-pandemic era